NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 12, 2011, Pages 1725-1738

  Dvorak, Christopher C ^a   Gracia, Clarisa R ^b   Sanders, Jean E ^c   Cheng, Edward Y ^d   Scott Baker, K ^c   Pulsipher, Michael A ^e   Petryk, Anna ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c USA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Growth failure; Infertility; Late effects; Pediatric allogeneic transplantation; Pediatric autologous transplantation; Thyroid dysfunction

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GONADORELIN AGONIST; GROWTH HORMONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYROID HORMONE;

ARTICLE; AVASCULAR NECROSIS; AZOOSPERMIA; BLOOD VESSEL INJURY; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASE; BONE NECROSIS; DELAYED PUBERTY; DYSLIPIDEMIA; GENDER; GONAD DYSFUNCTION; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTHYROIDISM; INFERTILITY; MALE INFERTILITY; OVARY INSUFFICIENCY; PREGNANCY OUTCOME; PUBERTY; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOSIS; THYROID DISEASE;

ADOLESCENT; ADULT; BONE AND BONES; CHILD; ENDOCRINE SYSTEM DISEASES; FEMALE; GROWTH DISORDERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NATIONAL CANCER INSTITUTE (U.S.); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); REPRODUCTION; RISK FACTORS; THYROID DISEASES; UNITED STATES; YOUNG ADULT;

EID: 81255197717     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.10.006     Document Type: Article

References (136)

1. Baker K., Ness K., Weisdorf D., et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia 2010, 24:2039-2047.
2. Sanders J., Hoffmeister P., Woolfrey A., et al. Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. Blood 2009, 113:306-308.
3. Bailey H., Kappy M., Giller R., Gralla J. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation. Pediatr Blood Cancer 2008, 51:405-409.
4. Ishiguro H., Yasuda Y., Tomita Y., et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab 2004, 89:5981-5986.
5. Michel G., Socié G., Gebhard F., et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation-a report from the Société Française de Greffe de Moelle. J Clin Oncol 1997, 15:2238-2246.
6. Afify Z., Shaw P., Clavano-Harding A., Cowell C. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000, 25:1087-1092.
7. Slatter M., Gennery A., Cheetham T., et al. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning. Bone Marrow Transplant 2004, 33:949-953.
8. Berger C., Le-Gallo B., Donadieu J., et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 2005, 35:991-995.
9. Leung W., Ahn H., Rose S.R., et al. A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 2007, 86:215-224.
10. Dvorak C., Wright N., Wong W., et al. Safety of hematopoietic stem cell transplantation in children less than three years of age. Pediatr Hematol Oncol 2008, 25:705-722.
11. Sanders J.E., Woolfrey A.E., Carpenter P.A., et al. Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood 2011, 118:1421-1428.
12. Socie G., Salooja N., Cohen A., et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003, 101:3373-3385.
13. Katsanis E., Shapiro R., Robison L., et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990, 5:335-340.
14. Savani B., Koklanaris E., Le Q., Shenoy A., Goodman S., Barrett A. Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2009, 15:377-381.
15. Ishiguro H., Yasuda Y., Tomita Y., et al. Gonadal shielding to irradiation is effective in protecting testicular growth and function in long-term survivors of bone marrow transplantation during childhood or adolescence. Bone Marrow Transplant 2007, 39:483-490.
16. MacMillan M., Blazar B., DeFor T., Dusenbery K., Wagner J. Thymic shielding (TS) in recipients of total body irradiation (TBI) and alternative donor hematopoietic stem cell transplant (AD-HSCT): reduced risk of opportunistic infection in patients with Fanconi anemia (FA). Blood 2006, 108. Abstract #3134.
17. van Kempen-Harteveld M., van Weel-Sipman M., Emmens C., et al. Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits. Bone Marrow Transplant 2003, 31:1151-1156.
18. Savani B., Montero A., Wu C., et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11:223-230.
19. Byrd J., Dow N., Gaertner E., et al. Leukemic thyroiditis as the initial relapsing sign in a patient with acute lymphocytic leukemia and blast expression of the neural cell adhesion molecule. Am J Hematol 1997, 55:212-215.
20. Massimino M., Gandola L., Pignoli E., et al. TSH suppression as a possible means of protection against hypothyroidism after irradiation for childhood Hodgkins lymphoma. Pediatr Blood Cancer 2011, 57:166-168.
21. Huma Z., Boulad F., Black P., Heller G., Sklar C. Growth in children after bone marrow transplantation for acute leukemia. Blood 1995, 86:819-824.
22. Giorgiani G., Bozzola M., Locatelli F., et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995, 86:825-831.
23. Cohen A., Rovelli A., Van-Lint M., et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996, 74:437-440.
24. Sanders J., Guthrie K., Hoffmeister P., Woolfrey A., Carpenter P., Appelbaum F. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 2005, 105:1348-1354.
25. Cohen A., Rovelli A., Bakker B., et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 1999, 93:4109-4115.
26. Brachet C., Heinrichs C., Tenoutasse S., Devalck C., Azzi N., Ferster A. Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2007, 29:445-450.
27. Eggleston B., Patience M., Edwards S., et al. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. Br J Haematol 2007, 136:673-676.
28. Li C., Chik K., Wong G., Cheng P., Lee V., Shing M. Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol 2004, 21:411-419.
29. Petryk A., Bergemann T.L., Polga K.M., et al. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 2006, 91:899-905.
30. Bhatia S., Ramsay N.K., Weisdorf D., Griffiths H., Robison L.L. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998, 22:87-90.
31. Nysom K., Holm K., Michaelsen K.F., et al. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 2000, 25:191-196.
32. Daniels M.W., Wilson D.M., Paguntalan H.G., Hoffman A.R., Bachrach L.K. Bone mineral density in pediatric transplant recipients. Transplantation 2003, 76:673-678.
33. Kaste S.C., Shidler T.J., Tong X., et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004, 33:435-441.
34. Perkins J.L., Kunin-Batson A.S., Youngren N.M., et al. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007, 49:958-963.
35. Carpenter P., Hoffmeister P., Chesnut C., et al. Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007, 13:683-690.
36. Weilbaecher K.N. Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000, 6:165-174.
37. Rodgers C., Monroe R. Osteopenia and osteoporosis in pediatric patients after stem cell transplant. J Pediatr Oncol Nurs 2007, 24:184-189.
38. McClune B.L., Polgreen L.E., Burmeister L.A., et al. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients. Bone Marrow Transplant 2011, 46:1-9.
39. Schulte C.M., Beelen D.W. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood 2004, 103:3635-3643.
40. Schimmer A.D., Minden M.D., Keating A. Osteoporosis after blood and marrow transplantation: clinical aspects. Biol Blood Marrow Transplant 2000, 6:175-181.
41. Banfi A., Podesta M., Fazzuoli L., et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer 2001, 92:2419-2428.
42. Castaneda S., Carmona L., Carvajal I., Arranz R., Diaz A., Garcia-Vadillo A. Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 1997, 60:343-347.
43. Lee W.Y., Baek K.H., Rhee E.J., et al. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant 2004, 34:89-94.
44. Baker K.S., Gurney J.G., Ness K.K., et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004, 104:1898-1906.
45. Stern J.M., Sullivan K.M., Ott S.M., et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant 2001, 7:257-264.
46. Ebeling P.R., Thomas D.M., Erbas B., Hopper J.L., Szer J., Grigg A.P. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999, 14:342-350.
47. Tauchmanova L., Colao A., Lombardi G., Rotoli B., Selleri C. Bone loss and its management in long-term survivors from allogeneic stem cell transplantation. J Clin Endocrinol Metab 2007, 92:4536-4545.
48. Baek K.H., Lee W.Y., Oh K.W., et al. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. J Clin Endocrinol Metab 2004, 89:1246-1254.
49. Galotto M., Berisso G., Delfino L., et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999, 27:1460-1466.
50. Withold W., Wolf H.H., Kollbach S., Heyll A., Schneider W., Reinauer H. Relationship between bone metabolism and plasma cytokine levels in patients at risk of post-transplantation bone disease after bone marrow transplantation. Eur J Clin Chem Clin Biochem 1996, 34:295-299.
51. Lee W.Y., Cho S.W., Oh E.S., et al. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 2002, 87:329-335.
52. Vega D., Maalouf N.M., Sakhaee K. CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 2007, 92:4514-4521.
53. Boyce B.F., Xing L. The RANKL/RANK/OPG pathway. Curr Osteoporos Rep 2007, 5:98-104.
54. Baek K.H., Oh K.W., Lee W.Y., et al. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism. Bone 2006, 39:1352-1360.
55. Kananen K., Volin L., Tahtela R., Laitinen K., Ruutu T., Valimaki M.J. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 2002, 29:33-39.
56. Atkinson K., Cohen M., Biggs J. Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty. Bone Marrow Transplant 1987, 2:421-426.
57. Faraci M., Calevo M.G., Lanino E., et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy. Haematologica 2006, 91:1096-1099.
58. Enright H., Haake R., Weisdorf D. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 1990, 89:733-738.
59. Socie G., Cahn J.Y., Carmelo J., et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol 1997, 97:865-870.
60. Mitchell D.G., Rao V.M., Dalinka M.K., et al. Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. Radiology 1987, 162:709-715.
61. Petrigliano F.A., Lieberman J.R. Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res 2007, 465:53-62.
62. Ojala A.E., Lanning F.P., Paakko E., Lanning B.M. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment. Med Pediatr Oncol 1997, 29:260-265.
63. Burger B., Beier R., Zimmermann M., Beck J.D., Reiter A., Schrappe M. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)-experiences from trial ALL-BFM 95. Pediatr Blood Cancer 2005, 44:220-225.
64. Strauss A.J., Su J.T., Dalton V.M., Gelber R.D., Sallan S.E., Silverman L.B. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001, 19:3066-3072.
65. Mattano L.A., Sather H.N., Trigg M.E., Nachman J.B. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the children's cancer group. J Clin Oncol 2000, 18:3262-3272.
66. Tauchmanova L., De Rosa G., Serio B., et al. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer 2003, 97:2453-2461.
67. Pritchett J.W. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 2001, 173-178.
68. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 2006, 73:500-507.
69. Assouline-Dayan Y., Chang C., Greenspan A., Shoenfeld Y., Gershwin M.E. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002, 32:94-124.
70. Hungerford D.S., Jones L.C. Asymptomatic osteonecrosis: should it be treated?. Clin Orthop Relat Res 2004, 124-130.
71. Jones K.B., Seshadri T., Krantz R., Keating A., Ferguson P.C. Cell-based therapies for osteonecrosis of the femoral head. Biol Blood Marrow Transplant 2008, 14:1081-1107.
72. Cherian S., Laorr A., Saleh K., Kuskowski M., Bailey R., Cheng E. Reliability and prognostic ability of quantifying the extent of femoral head involvement in osteonecrosis. J Bone Joint Surg Am 2003, 85A:309-315.
73. Mont M.A., Jones L.C., Einhorn T.A., Hungerford D.S., Reddi A.H. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop Relat Res 1998 Oct, (355 Suppl):S314-S335.
74. Campbell S., Sun C.L., Kurian S., et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009, 115:4127-4135.
75. Chang C.C., Greenspan A., Gershwin M.E. Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum 1993, 23:47-69.
76. Kerachian M.A., Harvey E.J., Cournoyer D., Chow T.Y., Seguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 2006, 13:237-244.
77. Schulte C.M., Beelen D.W. Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter. Transplantation 2004, 78:1055-1063.
78. Fink J.C., Leisenring W.M., Sullivan K.M., Sherrard D.J., Weiss N.S. Avascular necrosis following bone marrow transplantation: a case-control study. Bone 1998, 22:67-71.
79. Brown K.R., Rzucidlo E. Acute and chronic radiation injury. J Vasc Surg 2011, 53(Suppl):15S-21S.
80. Socie G., Selimi F., Sedel L., Frija J., Devergie A., Esperou Bourdeau H., et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol 1994, 86:624-628.
81. Holler E., Kolb H.J., Hiller E., et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989, 73:2018-2024.
82. Pettitt A.R., Clark R.E. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994, 14:495-504.
83. Willems E., Baron F., Seidel L., Frere P., Fillet G., Beguin Y. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplant 2010, 45:689-693.
84. Cruess R.L. Cortisone-induced avascular necrosis of the femoral head. J Bone Joint Surg Br 1977, 59:308-317.
85. Fryer J.P., Granger D.K., Leventhal J.R., Gillingham K., Najarian J.S., Matas A.J. Steroid-related complications in the cyclosporine era. Clin Transplant 1994, 8(Pt 1):224-229.
86. Tang S., Chan T.M., Lui S.L., Li F.K., Lo W.K., Lai K.N. Risk factors for avascular bone necrosis after renal transplantation. Transplant Proc 2000, 32:1873-1875.
87. Rosenthal J., Pawlowska A., Bolotin E., et al. Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus. Pediatr Blood Cancer 2011, 57:142-146.
88. Fortin M.C., Raymond M.A., Madore F., et al. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant 2004, 4:946-952.
89. Pizzolato G.P., Sztajzel R., Burkhardt K., Megret M., Borisch B. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. Neurology 1998, 50:1154-1157.
90. Vathsala A., Weinberg R.B., Schoenberg L., et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1989, 48:37-43.
91. Valimaki M.J., Kinnunen K., Volin L., et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 1999, 23:355-361.
92. Carlson K., Simonsson B., Ljunghall S. Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int 1994, 55:408-411.
93. Kang M.I., Lee W.Y., Oh K.W., et al. The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 2000, 26:275-279.
94. Hernigou P., Beaujean F., Lambotte J.C. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br 1999, 81:349-355.
95. Tauchmanova L., Serio B., Del Puente A., et al. Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2002, 87:5058-5065.
96. Forabosco A., Sforza C., De Pol A., Vizzotto L., Marzona L., Ferrario V.F. Morphometric study of the human neonatal ovary. Anat Rec 1991, 231:201-208.
97. Johnson J., Canning J., Kaneko T., Pru J.K., Tilly J.L. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004, 428:145-150.
98. Faddy M.J., Gosden R.G., Gougeon A., Richardson S.J., Nelson J.F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992, 7:1342-1346.
99. Hensley M.L., Reichman B.S. Fertility and pregnancy after adjuvant chemotherapy for breast cancer. Crit Rev Oncol Hematol 1998, 28:121-128.
100. Damewood M.D., Grochow L.B. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 1986, 45:443-459.
101. Shalet S.M. Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat Rev 1980, 7:141-152.
102. Shalet S.M., Didi M., Ogilvy-Stuart A.L., Schulga J., Donaldson M.D. Growth and endocrine function after bone marrow transplantation. Clin Endocrinol (Oxf) 1995, 42:333-339.
103. Schubert M.A., Sullivan K.M., Schubert M.M., et al. Gynecological abnormalities following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990, 5:425-430.
104. Sanders J.E., Hawley J., Levy W., et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996, 87:3045-3052.
105. Howell S.J., Shalet S.M. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005, 12-17.
106. Viviani S., Santoro A., Ragni G., Bonfante V., Bestetti O., Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 1985, 21:601-605.
107. Anserini P., Chiodi S., Spinelli S., et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant 2002, 30:447-451.
108. Sanders J. Growth and development after hematopoietic cell transplantation. Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation 2009, Wiley-Blackwell, Oxford, UK. S.J. Forman, F.R. Appelbaum, S.R. Negrin, K.G. Blume (Eds.).
109. Sanders J.E., Flournoy N., Thomas E.D., et al. Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease. Med Pediatr Oncol 1985, 13:165-172.
110. Hammond C., Abrams J.R., Syrjala K.L. Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol 2007, 25:3511-3517.
111. Lee S.J., Schover L.R., Partridge A.H., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006, 24:2917-2931.
112. Donnez J., Silber S., Andersen C.Y., et al. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann Med 2011, 43:437-450.
113. Andersen C.Y., Rosendahl M., Byskov A.G., et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 2008, 23:2266-2272.
114. Demeestere I., Simon P., Buxant F., et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod 2006, 21:2010-2014.
115. Donnez J., Dolmans M.M., Demylle D., et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004, 364:1405-1410.
116. Silber S., Kagawa N., Kuwayama M., Gosden R. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril 2010, 94:2191-2196.
117. Dolmans M.M., Marinescu C., Saussoy P., Van Langendonckt A., Amorim C., Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010, 116:2908-2914.
118. West E.R., Zelinski M.B., Kondapalli L.A., et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer 2009, 53:289-295.
119. Clowse M.E., Behera M.A., Anders C.K., et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 2009, 18:311-319.
120. Bedaiwy M.A., El-Nashar S.A., El Saman A.M., et al. Reproductive outcome after transplantation of ovarian tissue: a systematic review. Hum Reprod 2008, 23:2709-2717.
121. Beck-Fruchter R., Weiss A., Shalev E. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 2008, 14:553-561.
122. Meirow D., Rabinovici J., Katz D., Or R., Shufaro Y., Ben-Yehuda D. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer 2006, 107:1634-1641.
123. Quinn B., Kelly D. Sperm banking and fertility concerns: enhancing practice and the support available to men with cancer. Eur J Oncol Nurs 2000, 4:55-58.
124. Ohl D.A., Wolf L.J., Menge A.C., et al. Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility. Fertil Steril 2001, 76:1249-1255.
125. Wheeler J.S., Walter J.S., Culkin D.J., Canning J.R. Idiopathic anejaculation treated by vibratory stimulation. Fertil Steril 1988, 50:377-379.
126. Schwarzer J.U., Fiedler K., v Hertwig I., et al. Sperm retrieval procedures and intracytoplasmatic spermatozoa injection with epididymal and testicular sperms. Urol Int 2003, 70:119-123.
127. Schrader M., Muller M., Sofikitis N., Straub B., Krause H., Miller K. "Onco-tese": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines?. Urology 2003, 61:421-425.
128. Schover L.R., Brey K., Lichtin A., Lipshultz L.I., Jeha S. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002, 20:1890-1897.
129. Brook P.F., Radford J.A., Shalet S.M., Joyce A.D., Gosden R.G. Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation. Fertil Steril 2001, 75:269-274.
130. Wyns C., Curaba M., Vanabelle B., Van Langendonckt A., Donnez J. Options for fertility preservation in prepubertal boys. Hum Reprod Update 2010, 16:312-328.
131. Carter A., Robison L.L., Francisco L., et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 2006, 37:1023-1029.
132. Salooja N., Szydlo R.M., Socie G., et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001, 358:271-276.
133. Loren A.W., Chow E., Jacobsohn D.A., et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 2010, 17:157-166.
134. Green D.M., Whitton J.A., Stovall M., et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 2002, 187:1070-1080.
135. Signorello L.B., Cohen S.S., Bosetti C., et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst 2006, 98:1453-1461.
136. Green D.M., Whitton J.A., Stovall M., et al. Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003, 21:716-721.